Research output

  1. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

    Research output: Contribution to journal › Article › Academic › peer-review

  3. SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis

    Research output: Contribution to journal › Article › Academic › peer-review

View all (11) »

ID: 13616182